REALTA HOLDINGS LLC has a total of 19 patent applications. Its first patent ever was published in 2011. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are GENTICEL, MOMOTARO GENE INC and CYTOS BIOTECHNOLOGY AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Enzymes | |
#6 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Cunnion Kenji | 18 |
#2 | Krishna Neel K | 15 |
#3 | Krishna Neel | 3 |
#4 | Shah Tushar | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020243220A1 | Pic1 peptide compositions and methods of use thereof for treatment of hypoxic ischemic encephalopathy | |
US2019256561A1 | Synthetic peptide compounds and methods of use | |
KR20200138168A | PIC1 inhibition of myeloperoxidase oxidative activity in animal models | |
EP3313865A2 | Synthetic peptide compounds and methods of use | |
US2016376322A1 | Derivative peptide compounds and methods of use |